Binge Eating Disorder |
BED |
Clinical Trial: Comparing Two Group Therapy Treatments for Binge Eating Disorder
This study is currently recruiting patients.
|
Purpose
The purpose of this study is to compare two different approaches for the treatment of Binge Eating Disorder (BED).
| Condition | Treatment or Intervention | Phase |
|---|---|---|
| Eating Disorders | Behavior: Group Psychotherapy-Negative Emotion Focus Behavior: Group Psychotherapy- Self-Esteem Focus | Phase IV |
MedlinePlus related topics: Eating Disorders
Study Type: Interventional
Study Design: Treatment, Randomized, Open Label, Active Control, Parallel Assignment, Efficacy Study
Official Title: Comparison of DBT and Supportive Therapy for BED
Expected Total Enrollment: 100
Study start: October 2003
BED is associated with impairments in physical, psychological, and social functioning. Research has revealed relationships between disordered eating and both low self-esteem and negative emotional states.
Participants in this study will complete assessment interviews regarding their eating disorder and associated problems. Similar assessments will be conducted at the end of the study. Participants will then be randomly assigned to one of two therapy groups. Participants in one group will focus on the role of self-esteem, self-awareness, and personal effectiveness in binge eating. Participants in the other group will focus on the role of negative emotions and binge eating. Both treatments will involve a 30 to 40 minute pre-treatment individual orientation session, followed by 20 weeks of weekly group therapy. Sessions will take place over 22 weeks, or approximately 6 months (18 weekly sessions followed by 2 biweekly sessions). Follow-up assessments will take place at 3 months, 6 months, and 12 months after study completion to assess maintenance of treatment effects.
Eligibility
Ages Eligible for Study: 18 Years and above, Genders Eligible for Study: Both
Criteria
Inclusion Criteria:
- Diagnosis of Binge Eating Disorder
- Reside in the San Francisco Bay Area
- Willing to commit to the study requirements
Exclusion Criteria:
- Unstable medical problems
- History of bipolar illness or schizophrenia
- Receiving treatment for an eating disorder (or unwillingness to discontinue treatment upon study entry)
- Membership in weight-loss groups such as Weight Watchers or Jenny Craig (or unwillingness to discontinue membership upon study entry)
- Use of medications affecting weight or appetite. Antidepressants are acceptable, but doses of any psychiatric medication must have been stable for at least 3 months prior to study start
- Breast-feeding
- Require gastric-bypass surgery
Location and Contact Information
California
Stanford University Medical Center, Stanford, California, 94305-5722, United States; Recruiting
Debra Safer, MD 650-723-7928 DLSAFER@STANFORD.EDU
Debra Safer, MD, Principal Investigator
More Information
Record last reviewed: September 2004
Last Updated: October 13, 2004
Record first received: October 29, 2003
ClinicalTrials.gov Identifier: NCT00071578
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2005-04-08
Source: ClinicalTrials.gov
Cache Date: April 9, 2005
Resources
- Anorexia nervosa (MayoClinic)
- Binge Eating Disorder (National Eating Disorders Association)

Not Signed In -

